Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal Mental Health (MAMA) Study
2020-001592-33Phase 2Active
- Sponsor
- Rigshospitalet
- Start
- Jun 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postpartum depression (PPD) and Maternal depression (PND) comparing Estradiol with Placebo (2 arms). Primary endpoint: Clinical depression according to DSM-V criteria. Started Jun 2020; status: active.
02
Drugs
estradiol
03
Conditions
postpartum depression (PPD)Maternal depression (PND)
Beyond the preview
Go deeper on 2020-001592-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001592-33.